Showing 201-210 of 767 results for "".
Pain Relief for Next April 15th
https://practicaldermatology.com/topics/practice-management/pain-relief-for-next-april-15th/21197/Tax-saving ideas you can do now.Critical Factors to Advancing Melanoma Diagnosis and Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/critical-factors-to-advancing-melanoma-diagnosis-and-treatment/22970/Dermatologists need to stay abreast of technologies for evaluation of lesions and ensure that medical oncologists within their referral network recognize the importance of clinical trials.Targeting Cellulite: Evolving Approaches
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/targeting-cellulite-evolving-approaches/23796/New treatments mean that dermatologists can improve treatment outcomes for the 90% of women who have cellulite.New Products
https://practicaldermatology.com/columns/new-products/new-products-1/23341/New in My Practice: Cosmeceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceuticals-3/23826/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20748/DermWireTV: Zoryve Approved; New SDPA President; Project Determi-Nation; Stelara for Pediatric PsA
https://practicaldermatology.com/topics/psoriasis/dermwiretv-zoryve-approved-new-sdpa-president-project-determi-nation-stelara-for-pediatric-psa/20115/FDA has approved Zoryve from Arcutis Biotherapeutics for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older. The novel formulation of roflumilast cream 0.3% is indicated for once-daily application. Stelara (ustekinumab) from Janssen is now approveCosmeceuticals Series, Part 2: Antioxidants
https://practicaldermatology.com/topics/general-topics/cosmeceuticals-series-part-2-antioxidants/21395/The second article in this quarterly series examines how cosmeceuticals containing antioxidants can mitigate UV-induced damage.Revisiting Facial Seborrheic Dermatitis: A New Therapeutic Option
https://practicaldermatology.com/topics/general-topics/PD0109_05-php/22892/A popular topical agent offers anti-inflammatory, antibacterial, and sebosuppressive effects that could prove useful for management of seborrheic dermatitis.Across the Lifespan: Understanding the Cutaneous Impact of Hormonal Fluctuations on Women’s Skincare
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/across-the-lifespan-understanding-the-cutaneous-impact-of-hormonal-fluctuations-on-womens-skincare/24027/Drs. Hope Mitchell, Mary Lupo, and Elizabeth Houshmand, talk with Practical Dermatology® about the unique challenges of tailoring women’s skincare to their specific needs.